# Yong Huo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yong-huo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,196 |
| Field | Acute Myocardial Infarction Research |
| h-index | 63 |
| i10-index | 337 |
| Last Known Institution | Sun Yat-sen University |
| OpenAlex ID | https://openalex.org/A5080427269 |
| ORCID iD | https://orcid.org/0000-0002-5407-8773 |
| Works | 862 |

## Researcher papers

- [Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effect-of-interleukin-1-inhibition-with-canakinumab-on-incident-lung-cancer-in/)
- [Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial](https://scholariq.org/papers/relationship-of-c-reactive-protein-reduction-to-cardiovascular-event-reduction/)
- [Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China](https://scholariq.org/papers/efficacy-of-folic-acid-therapy-in-primary-prevention-of-stroke-among-adults-with/)
- [Efficacy of folic acid supplementation in stroke prevention: a meta-analysis](https://scholariq.org/papers/efficacy-of-folic-acid-supplementation-in-stroke-prevention-a-meta-analysis/)
- [Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial](https://scholariq.org/papers/effects-of-alirocumab-on-cardiovascular-and-metabolic-outcomes-after-acute/)
- [Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effects-of-acarbose-on-cardiovascular-and-diabetes-outcomes-in-patients-with/)
- [Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients](https://scholariq.org/papers/primacy-of-the-3b-approach-to-control-risk-factors-for-cardiovascular-disease-in/)
- [A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial](https://scholariq.org/papers/a-multifaceted-intervention-to-improve-treatment-with-oral-anticoagulants-in/)
- [Hourly Air Pollutants and Acute Coronary Syndrome Onset in 1.29 Million Patients](https://scholariq.org/papers/hourly-air-pollutants-and-acute-coronary-syndrome-onset-in-1-29-million-patients/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Folate and B Vitamins Research](https://scholariq.org/topics/folate-and-b-vitamins-research/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)

## Researcher university

- [Sun Yat-sen University](https://scholariq.org/institutions/sun-yat-sen-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.